Labormar completed the acquisition of Pharmia from CapMan.

Labormar, a B2B innovation-driven CDMO, completed the acquisition of Pharmia, a manufacturer of food supplements and medical devices, from CapMan Buyout, a private equity arm. Financial terms were not disclosed. “During CapMan Buyout’s ownership period, Pharmia has successfully executed its growth strategy. I want to thank Pharmia’s management and personnel, as well as my board colleagues, for making this a successful investment," Anders Björkell, CapMan Buyout Partner.